PIM1 and ovarian cancer: Indeed, a 4-aza podophyllotoxin derivative was demonstrated to act as a potent in vitro inhibitor of the GBP1:PIM1 interaction, which is a property that is maintained in vivo in ovarian cancer cells resistant to paclitaxel [90].